Skip to content

The mechanism of gynecological cancer-related anemia and Treatment Strategies

The mechanism of gynecological cancer-related anemia and Treatment Strategies

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009059
Enrollment
Unknown
Registered
2016-08-22
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecology cancer-related anemia

Interventions

NC:Collect blood
Therapy group1:Subcutaneous injection of EPO and and intravenous iron therapy, Collect blood
Therapy group2:Subcutaneous injection of EPO and Oral iron therapy, Collect blood
Therapy group3:Intravenous iron therapy, Collect blood
Therapy group4:Oral iron therapy, Collect blood

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged elder than 18 years, ECOG score 0, 1, or 2; 2. Hb<110 g/L, HCT<0.3, MCV<80fl, MCH <27pg, MCHC<0.32, sEPO<200mu/ml, SI<8.95 umol/L, sFer<800ug/L, SF<12ug/L, TSAT<50%; 3. It is not used within 10 days of iron treatment before, treatment without prior history of blood transfusion within 30 days, without erythropoietin treatment history, no history of corticosteroid therapy.

Exclusion criteria

Exclusion criteria: 1. Anemia caused by other reasons (such as gastrointestinal bleeding or blood shortage of raw materials such as metabolic disorders) or with blood diseases; 2. Suspicion or diagnosis of bone metastases in patients with brain metastases to check the liver and kidney function of heart function were normal without hypertension coronary heart disease, etc.; 3. Expected survival time> 3 months.

Design outcomes

Primary

MeasureTime frame
Hb;

Secondary

MeasureTime frame
sEPO;serum iron;sFer;sTF;TSAT;TSAT;

Countries

China

Contacts

Public ContactShen Huimin

The First Affiliated Hospital of Sun Yat-sen University

Huimin_shen@126.com+86 13822232221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026